Search Site

Laval, QC, Canada

In 2009, Vertex established its Canadian research and development site in Laval, Quebec, Canada through the acquisition of ViroChem Pharma. Today, Vertex’s Laval scientists are focused on developing new approaches to the treatment of Crohn’s disease, ulcerative colitis and other diseases.

Vertex Pharmaceuticals (Canada) Incorporated

Vertex Pharmaceuticals (Canada) Incorporated
275 Armand-Frappier
Laval (Quebec) H7V 4A7 Canada

Tel: 450-978-7700
Fax: 450-978-7972


Read more about what it's like to work here.

Last updated: Thursday, October 24, 2013 - 15:28